BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

GlaxoSmithKline (Cidra, Puerto Rico) 

P.O. Box 11975

Cidra    00739  Puerto Rico
Phone: 787-250-3700 Fax: 787-250-3857


SEARCH JOBS




Industry
Healthcare

Segment
Pharmaceuticals





 Company News
ADHD Drugs To Have Stronger Warning; Include Novartis International AG (NVS)'s Dexedrine And GlaxoSmithKline Biologicals (GSK)'s Ritalin 8/22/2006 8:23:53 AM
GlaxoSmithKline (GSK) Release: FDA Approves ZOFRAN(R) For Use In Children As Young As One Month Of Age10/19/2005 5:13:09 PM
Hoffmann-La Roche (New Jersey) (RHHBY) And GlaxoSmithKline (GSK) Annouce FDA Approves Once-Monthly Boniva(R) For Osteoporosis First-Ever Monthly Single Tablet For Any Disease10/19/2005 5:13:07 PM
GlaxoSmithKline Consumer Healthcare Launches Suit To Stop Misleading Marketing Of Unproven Herbal Smoking Cessation Therapy10/19/2005 5:12:40 PM
GlaxoSmithKline (GSK) HIV Drug Gets Approval10/19/2005 5:12:31 PM
Flamel Technologies (FLML) Announces Completion Of A Commercial Supply Agreement With GlaxoSmithKline (GSK) For Drug In Phase III Trials10/19/2005 5:12:30 PM
Neurocrine Biosciences, Inc. (NBIX) Announces Initiation Of Phase I Trial With CRF1 Antagonist For Anxiety And Depression10/19/2005 5:12:27 PM
GlaxoSmithKline (GSK) Acquires Full Marketing And Development Rights For BEXXAR Worldwide10/19/2005 5:12:26 PM
GlaxoSmithKline (GSK) Launches Hepsera Oral Antiviral Drug For Chronic Hepatitis B Infection10/19/2005 5:12:25 PM
Dynavax Technologies Corporation (DVAX) Announces Positive Interim Results From Phase 2/3 Hepatitis B Vaccine Trial10/19/2005 5:12:25 PM
12345